Latest AHRQ funding to focus on IT, patient safety

The Agency for Healthcare Research and Quality (AHRQ) will fund ambulatory care and long-term care facilities to research strategies to improve patient safety through IT and other evidence-based tools.

This funding opportunity will support investigative research projects that examine the epidemiology of patient safety in these environments, gather evidence on strategies that can improve safety and develop tools to implement the strategies, according to AHRQ.

The total amount of funding and number of awards are contingent on AHRQ appropriations and submission of sufficient “meritorious” applications.

The work should “include a focus on issues that are relevant to underserved and vulnerable populations which include federally qualified health centers, community health centers, safety-net hospital outpatient departments, physician offices and long-term care facilities,” according to the agency's announcement.

The project has a specific research focus on understanding and eliminating disparities in patient and resident safety. Long-term care facilities under this funding opportunity include nursing homes, assisted living homes, residential care homes and home care.

Specific areas of interest include incident studies of medical errors and subsequent adverse events in different types of ambulatory care; human, system and other factors that contribute to errors; and evidence-based studies of intervention strategies. Research may include new or existing technologies to aid in preventing adverse events including use of electronic health records to improve prevention, as well as use of current “low technology” approaches that provide new tools.

Funding won't exceed $500,000 in any given year or a total of $1,500,000 for the entire project period, according to the announcement, and the project period may not exceed three years.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.